New York-based private equity company Avista Capital Partners in the US has acquired Terrats Medical, a dental prosthetics, abutments and implants provider, from Miura Partners.
The financial terms of the deal were undisclosed.
Established in 1947, Terrats Medical is a Spain-based company that specialises in manufacturing and marketing a range of dental prosthetics and related products.
The company’s clientele spans dental offices, laboratories, distributors, and original dental implant equipment manufacturers who buy products from Terrats on a private-label basis.
Terrats Medical has a strong international presence, with exports comprising over 95% of its revenue and sales in more than 50 countries.
See Also:
Miura Partners has been investing in Terrats since 2020 and has supported Terrats in implementing various strategic initiatives that have tripled its overall sales.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataSome of these initiatives include enhancing direct sales with the DESS Dental Smart Solutions brand, launching an implantology business, advancing its digital strategy, and acquiring distributors Geryon in the US and Sweden’s Humanus Dental.
Avista’s acquisition of Terrats is expected to support the latter’s growth in the international market, particularly in the US.
It will also help in enhancing Terrats’ financial and global positioning, enabling further expansion and exploration of new inorganic growth opportunities.
The founders of Terrats Medical have reinvested in the company and will continue to spearhead the business post-acquisition.
Miura has also reinvested in Terrats, demonstrating its ongoing support for Terrats Medical’s future growth.
Advisory services for the transaction were provided to Miura by Moelis & Company for merger and acquisitions, KPMG for due diligence, and Clifford Chance for legal counsel.
For Avista, Deloitte provided due diligence services while Ropes & Gray and Uría provided legal matters advice for the transaction.
Terrats CEO Roger Terrats said: “Our vision for the next stage will be very consistent and focused on global growth, with a top-notch product suite and strong sales network that will be fortified in the coming years. Additionally, we look forward to continuing to invest in our production and our team.”
